C

CRISP-HR Therapeutics, Inc.

3 employees

CRISP-HR a therapeutics company has developed a proprietary, next-generation CRISPR platform to create novel therapeutics for rare diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Immunotherapeutics
CRISPR
Cas9-HR
Immune
Homologous Recombination
Stem Cell
Metabolic
Cas9 Fusion Proteins
Double Strand Break (DSB)
Cellular Therapeutics
Medicine
Life Sciences
Genetic Engineering
Cas9-HR Platform
DNA
Therapeutics
DNA Editing
Gene Editing Platforms
Cas9
Genomic Editing
Life Science
Health Sciences

Date founded

2019

Funding rounds raised

C

CRISP-HR Therapeutics, Inc. raised undisclosed on March 16, 2022

Investors: Illumina For Startups

FAQ